Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: BIOCRYST PHARMACEUTICALS INC
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2024-03-04 to 2024-10-04
Current total value of award: $201721.59
Description: ORLADEYO 150MG CAPS